Nope, you're still playing your silly little games,

New Post Public Reply Private Reply Replies (0) Message Board
Phteven C scgmck1 #35705
358
Quote:
Nope, you're still playing your silly little games, pinhead. I'll answer your attempt to gain our trust just this once.


There's no need for mudslinging and name calling. You seem so eager to disagree with me. It seems you need a history lesson in your own company.

Quote:
B is NOT on hold indefinitely


A straw man. I never said B was on hold - an obvious fact as we have two trials ongoing. I said B-ABSSSI P3 is on hold indefinitely until more funding is raised or a deal of some kind provides that funding. If you happen to have a specified date of initiation let me know what it is. Otherwise you should look up the definition of indefinite.

Quote:
a P ph 2B trial is NOT a reason our MC is so low


The necessity of a Prurisol phase 2B with a higher dosage on the mod-severe population meant that it was reasonable to assume that a Prurisol deal was not going to happen in 2016. After the lack luster response to the results it became clear that Prurisol was not going to be a stock price mover in 2016.

Quote:
B OM has had recruitment issues that are totally out of mgmt.'s control


Correct. I didn't say it was management's fault. The trial completion date moving from Dec 2016 to Dec 2017 did not in any way help the share price. It removed B-OM as a stock price mover in 2016.

Quote:
K AML was never to be funded by IPIX but by the Italians


Another straw man as I never said it was funded by IPIX. It was the Italians who dropped the ball on the funding and it pushed our first Kevetrin phase 2 initiation from late 2015/ early 2016 (K-AML) to early 2017(K-OC). Another delay of a year. That didn't help the stock price.

Quote:
I don't give 2 shits that you're "CONvinced" that there is no NS going on-I AM convinced that there is. I am also convinced that you are one of the players in this takedown scheme and are posting here to gain some credence in some doubters minds.


Credence in doubters minds? With my bullish lauding of the pipeline/management and my divinely inspired prophecy of $70 following the fulfilled fall to $0.70? Your unfounded hatred of the prophetic fulfillment has clearly blinded you from anything I am saying. I couldn't care less what other people believe as the prophecy will be fulfilled.

Quote:
You will show your colors again. In the meantime, do not bother answering anything I post if you expect me to offer an answer. I won't do it. I know who you are and I know why you are here. The rest of us do too.


I don't expect you to but your claims which include outright falsehood need to be answered.

Quote:
I am here because of the science that is solidly behind IPIX, not because I'm a trader, flipper, short or paid basher con artist like yourself.


I too believe in the science and am very excited for what I hope are four phase 2 trial successes to add to the current ones. I am not a trader, flipper, short or paid basher as you fallaciously claim.

Quote:
I stay invested because the science has proven positive thus far. We should be trading well above the $5/$6 range currently, if not for the efforts of people such as you


I also believe we are worth around $5 currently. You seem to be blaming me but the day I stopped commenting on this stock in early 2016 the share price was around $1.80. I started commenting again here when the price hit $0.70 and now the stock is $1.00. So it seems, contrary to your opinion, my presence is both inspiring and highly beneficial to the stock price. If I was a paid basher I'd have been fired long ago.

It's ok to dislike me and my opinions but please don't continue to make things up about me and answer arguments I didn't make.

Go IPIX!
1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aspen Dental Brings Comprehensive Care to Whiteville

Updated Category News Views 5

Bringing Dentistry Closer to Home Now, Whiteville's dental game just got a power-up, with Aspen Dental setting up shop in town. This isn't just another practice popping up—it's a full-on dental hub offering everything from regular cleanings to emergency tooth fixes. And let’s face it, this area's diverse population needs it. The Man Behind the Chair Guess who’s at...

Continue Reading
Steel Dynamics Gears Up for Q3 2026 Earnings Update

Updated Category News Views 6

Steel Dynamics Preps for Key Earnings Report Folks, we're staring down the barrel of another quarterly earnings report from Steel Dynamics, Inc., and you can bet this one is gonna have plenty of eyes glued. October 19th, 2026, that's when they'll peel back the curtain on how they fared in Q3. Now, buckle up, because this isn't just a numbers game—it’s a snapshot of...

Continue Reading
Hexaware Teams with Anthropic for Game-Changing AI Move

Updated Category News Views 4

A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...

Continue Reading
Lupin Secures FDA Nod for Key Injectable Drug

Updated Category News Views 4

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

Continue Reading
Webull Faces Legal Scrutiny Over Chinese Ties

Updated Category News Views 5

The Unfolding Drama for Webull Shareholders When you see a ticker like NASDAQ:BULL rolling off your tongue these days, it’s not just about stock prices anymore—it's a whole saga wrapped in legal and geopolitical spice. Following the recent uproar from a House China committee report, Webull found itself thrust into the spotlight for all the wrong reasons. That report...

Continue Reading
Teamsters Secure Landmark Deal for SF Parking Workers

Updated Category News Views 4

Major Win for San Francisco's Parking Professionals Parking lots and garages across San Francisco might not be the first places you’d look for labor triumphs, but that’s exactly what almost 1,000 members of Teamsters Local 665 have achieved. Under a newly ratified four-year master contract, these parking pros snagged one of the richest deals the industry has seen. A...

Continue Reading
Mexico's Beaches Shine in 2026 Best America Rankings

Updated Category News Views 5

Mexican Shores Turning Heads in 2026 This isn’t just another wave in tourism news; it’s a tidal shift towards Mexico’s sizzling beaches claiming some prime spots on the global travel stage. If you’ve got an eye for tourism dynamics, listen up because Mexico’s sun-soaked shores just snagged six spots among the top 20 beaches in the Americas, according to the...

Continue Reading
Ardelyx Securities Fraud Suit: Key Investor Moves

Updated Category News Views 5

Fraud Allegations: Ardelyx Under the Microscope Looks like Ardelyx has found itself neck-deep in trouble, facing a class action lawsuit over alleged securities fraud. This isn't just a storm in a teacup. We're talking about accusations of false and misleading statements tied to their commercial performance—statements that might have left investors holding the bag with...

Continue Reading
Full Sail University Bags Billboard Music School Honor

Updated Category News Views 6

Full Sail Scores a Billboard Nod — What's the Big Deal? Alright, Full Sail University just snagged a spot on Billboard Magazine's 2026 Top Music Business Schools list. That's no small fry, folks. This Florida institution has been carving out a niche in the music business education scene with a hands-on learning approach that hits the nail right on the head. The Recipe...

Continue Reading
Striveworks: Boosting Army's AI Edge in Indo-Pacific

Updated Category News Views 6

The world keeps marching forward, and here’s Striveworks stepping up to the plate with another big move in the military tech space. This isn't your average partnership renewal; this involves a five-year, $200 million deal to enhance battlefield AI as the U.S. Army hones its modern warfare edge in the Indo-Pacific. Now, this isn't just a battle of strategies but a battle...

Continue Reading

Top 5 Most Recently Viewed Articles

Cloudflare's Exceptional Quarter: Is It Time to Reassess Value?

Updated Category News Views 205

Cloudflare Achieves Impressive Revenue Growth Cloudflare Inc. (NYSE: NET) has once again demonstrated strong performance with its latest quarterly results, showcasing significant revenue growth and improved customer metrics. This achievement underscores the company’s capacity for success and the expanding demand for its services, particularly in the enterprise sector....

Continue Reading
GameStop's Strategic Move to Sell Its International Assets

Updated Category News Views 539

GameStop's New Strategy for International Growth GameStop Corp. (NYSE: GME) has taken a significant step in aligning its business strategy with current market conditions by announcing its intent to sell its operations in France and Canada. This decision reflects a broader assessment of international assets that the company is undertaking to streamline its operations and...

Continue Reading
Understanding Regulatory Disclosures for Life Science REIT

Updated Category News Views 113

Introduction to Disclosure Requirements In the investment landscape, transparency is vital. This is especially true for companies like Life Science REIT Plc, which must adhere to specific regulations when it comes to public disclosures. Understanding these requirements can help investors navigate their investments more effectively. Key Information About Disclosures When a...

Continue Reading
LGI Homes Faces Criticism Over High Foreclosure Rates

Updated Category News Views 214

LGI Homes Under Fire for Deceptive Practices Shares of homebuilder LGI Homes Inc (NASDAQ: LGIH) have seen a dip as a recent report raises serious allegations about the company's marketing strategies. The report highlights concerns over deceptive marketing tactics that encourage potential buyers to consider homes that may be out of their financial reach. Key Concerns from...

Continue Reading
Apple Facing Leadership Changes Amid AI Development Concerns

Updated Category News Views 251

Significant Changes in Apple’s Executive Team Apple Inc. (NASDAQ: AAPL) is undergoing a noteworthy transformation within its top management as several high-profile personnel and engineers depart from the organization. Among these exits are crucial figures leading artificial intelligence and interface design, indicating an unprecedented wave of turnover that could impact...

Continue Reading